Purification of a peptide from seahorse, that inhibits TPA-induced MMP, iNOS and COX-2 expression through MAPK and NF-kappaB activation, and induces human osteoblastic and chondrocytic differentiation.
about
Metalloproteinase inhibitors: status and scope from marine organismsMarine Fish Proteins and Peptides for Cosmeceuticals: A Review.Seahorse-derived peptide suppresses invasive migration of HT1080 fibrosarcoma cells by competing with intracellular α-enolase for plasminogen binding and inhibiting uPA-mediated activation of plasminogenA comparative study of mechanical strain, icariin and combination stimulations on improving osteoinductive potential via NF-kappaB activation in osteoblast-like cellsThe role of PIN1 on odontogenic and adipogenic differentiation in human dental pulp stem cells.Seahorses - a source of traditional medicine.Schisandrae Fructus Inhibits IL-1β-Induced Matrix Metalloproteinases and Inflammatory Mediators Production in SW1353 Human Chondrocytes by Suppressing NF-κB and MAPK Activation.Myricetin suppresses lipoteichoic acid-induced interleukin-1β and cyclooxygenase-2 expression in human gingival fibroblasts.Optimization of hydrolysis conditions, isolation, and identification of neuroprotective peptides derived from seahorse Hippocampus trimaculatus.Involvement of p38MAPK/NF-κB signaling pathways in osteoblasts differentiation in response to mechanical stretch.Effects of fish collagen peptides on collagen post-translational modifications and mineralization in an osteoblastic cell culture system.The osteogenic differentiation stimulating activity of Sea cucumber methanolic crude extraction on rat bone marrow mesenchymal stem cells.Protective Effects of LSGYGP from Fish Skin Gelatin Hydrolysates on UVB-Induced MEFs by Regulation of Oxidative Stress and Matrix Metalloproteinase Activity.Inhibitory effect of phytoglycoprotein (38 kDa) on expression of matrix metalloproteinase-9 in 12-O-tetradecanoylphorbol-13-acetate-treated HepG2cells.
P2860
Q21296828-2BAE21DE-94CF-4431-BB9F-6E2D94E1AF01Q33744165-9D918E1B-87FD-469B-93FB-72DB15BDD9DEQ35134419-FC84C2D1-EDDF-41F8-A7E3-D3CA402116F3Q35683486-BDB094E6-6A52-45B2-9AA5-2C88A188CD79Q37610703-2BA36495-9CEB-4651-B591-BBB4B26725B5Q37987633-77F30F57-F84D-433B-A8E9-B52FAE33767BQ38829875-66A961CD-5AE5-4933-9D93-4500A0E63903Q39080848-A3D6E061-C603-4662-B754-DAEC06C5ECD9Q39148412-4D7CCBAC-3E26-426A-92E1-00013BBDB552Q42797916-D2C9F770-BFEA-4DCF-A77C-9223A97EF840Q42826099-95DD4FBD-A3E4-43B1-9511-1A2C14102FC9Q43023159-8B4E0B2E-F3FD-43B5-8A92-63762B4FB8D4Q54118684-C6FFBB8E-699F-49D6-8BB5-B68304E25858Q54578273-A0331336-6031-4BFD-B571-DD75E8993379
P2860
Purification of a peptide from seahorse, that inhibits TPA-induced MMP, iNOS and COX-2 expression through MAPK and NF-kappaB activation, and induces human osteoblastic and chondrocytic differentiation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Purification of a peptide from ...... chondrocytic differentiation.
@en
Purification of a peptide from ...... chondrocytic differentiation.
@nl
type
label
Purification of a peptide from ...... chondrocytic differentiation.
@en
Purification of a peptide from ...... chondrocytic differentiation.
@nl
prefLabel
Purification of a peptide from ...... chondrocytic differentiation.
@en
Purification of a peptide from ...... chondrocytic differentiation.
@nl
P1476
Purification of a peptide from ...... chondrocytic differentiation.
@en
P2093
Zhong-Ji Qian
P304
P356
10.1016/J.CBI.2009.12.003
P577
2009-12-11T00:00:00Z